| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |